Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

作者:Feng Wang, Ying Jin, Min Wang, Hui Luo, Weijia Fang, Yingnan Wang, Yan‐Xing Chen, Run-Jie Huang, Wen‐Long Guan, Jibin Li, Yuhong Li, Feng‐Hua Wang, Xiaohua Hu, Yanqiao Zhang, Miao‐Zhen Qiu, Lulu Liu, Zixian Wang, Chao Ren, De‐Shen Wang, Dong‐Sheng Zhang, Zhi‐Qiang Wang, Wenting Liao, Lin Tian, Qi Zhao, Rui‐Hua Xu · 发表于:Nature Medicine · 年份:2024 · DOI:10.1038/s41591-024-02813-1 · 被引用次数:174 · 研究领域:Colorectal Cancer Treatments and Studies、Cancer Immunotherapy and Biomarkers、Genetic factors in colorectal cancer